UB
KRTX

UMB Bank’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

UMB Bank’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-475
Closed -$150K – 2207
2023
Q4 		$150K Hold
475
– – ﹤0.01% 637
2023
Q3 		$80.3K Sell
475
-4
-0.8% -$752 ﹤0.01% 729
2023
Q2 		$104K Buy
479
+4
+0.8% +$857 ﹤0.01% 691
2023
Q1 		$86.3K Sell
475
-75
-14% -$14.3K ﹤0.01% 728
2022
Q4 		$108K Hold
550
– – ﹤0.01% 683
2022
Q3 		$124K Hold
550
– – ﹤0.01% 681
2022
Q2 		$70K Hold
550
– – ﹤0.01% 824
2022
Q1 		$70K Hold
550
– – ﹤0.01% 869
2021
Q4 		$72K Buy
+550
New +$71.1K ﹤0.01% 886

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

UMB Bank's KRTX Position: Q1 2024 in Review

UMB Bank sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 475 shares — an estimated $150K sold.

UMB Bank first reported a position in KRTX in Q4 2021 and held it in 9 quarters. The position peaked at $150K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • UMB Bank reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • UMB Bank sold 475 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $150K.
  • UMB Bank first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • UMB Bank's Karuna Therapeutics, Inc. Common Stock position peaked at $150K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on UMB Bank's 13F filing for Q1 2024, filed 26 Apr 2024.